DARE - Dare Bioscience, Inc.
2.89
-0.010 -0.346%
Share volume: 9,741
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$2.90
-0.01
0.00%
View ratios
Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
---|---|---|---|---|
Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
Report Date | 05-14-2024 | 08-12-2024 | 11-14-2024 | |
Total revenue | 9.302 K | 22.438 K | 41.691 K | |
Cost of revenue | 0.000 | 0.000 | 0.000 | |
Gross profit | 9.302 K | 22.438 K | 41.691 K | |
141.22% | 85.81% | |||
Operating expenses | 5.999 M | 7.357 M | 4.698 M | |
Selling general and admin | 2.671 M | 2.448 M | 2.041 M | |
Research and development | 3.329 M | 4.909 M | 2.657 M | |
Total expenses | 6.032 M | 7.382 M | 4.723 M | |
22.38% | -36.02% | |||
Operating income | -6.022 M | -7.359 M | -4.681 M | |
Ebit | -6.755 M | -7.359 M | -4.703 M | |
Pretax income | -6.755 M | 13.020 M | -4.703 M | |
-292.73% | -136.12% | |||
Income tax | 0.000 | 0.000 | 0.000 | |
Net income basic | 0.000 | 0.000 | 0.000 | |
Net income | -6.755 M | 12.911 M | -4.703 M | |
291.12% | -136.42% |